0
0
0
SACKLER Act
3/13/2024, 5:20 PM
Summary of Bill S 2831
The SACKLER Act, also known as Bill 118 s 2831, is a piece of legislation introduced in the US Congress. The purpose of this bill is to hold pharmaceutical companies accountable for their role in the opioid crisis. The bill specifically targets the Sackler family, who are the owners of Purdue Pharma, the company responsible for manufacturing OxyContin.
The SACKLER Act aims to impose a tax on the profits made by pharmaceutical companies from the sale of opioids. This tax would be used to fund programs and initiatives aimed at addressing the opioid crisis, such as addiction treatment and prevention programs.
Additionally, the bill seeks to prevent the Sackler family from profiting off of the sale of opioids by requiring them to pay back any profits made from the sale of OxyContin. This would help ensure that those responsible for fueling the opioid crisis are held accountable for their actions. Overall, the SACKLER Act is a bipartisan effort to address the devastating impact of the opioid crisis and hold pharmaceutical companies accountable for their role in perpetuating it.
The SACKLER Act aims to impose a tax on the profits made by pharmaceutical companies from the sale of opioids. This tax would be used to fund programs and initiatives aimed at addressing the opioid crisis, such as addiction treatment and prevention programs.
Additionally, the bill seeks to prevent the Sackler family from profiting off of the sale of opioids by requiring them to pay back any profits made from the sale of OxyContin. This would help ensure that those responsible for fueling the opioid crisis are held accountable for their actions. Overall, the SACKLER Act is a bipartisan effort to address the devastating impact of the opioid crisis and hold pharmaceutical companies accountable for their role in perpetuating it.
Read the Full Bill
Current Status of Bill S 2831
Bill S 2831 is currently in the status of Bill Introduced since September 18, 2023. Bill S 2831 was introduced during Congress 118 and was introduced to the Senate on September 18, 2023.  Bill S 2831's most recent activity was Read twice and referred to the Committee on the Judiciary. as of September 18, 2023
Bipartisan Support of Bill S 2831
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
4Democrat Cosponsors
4Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2831
Primary Policy Focus
Finance and Financial SectorAlternate Title(s) of Bill S 2831
SACKLER Act
SACKLER Act
Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases Act
A bill to prohibit the non-consensual release of claims by States, municipalities, federally recognized Tribes, or the United States against non-debtors, and for other purposes.
Comments
Sponsors and Cosponsors of S 2831
Latest Bills
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Limited Applicability of Consumer Financial Protection Act's 'Time or Space' Exception With Respect to Digital Marketing Providers".
Bill SJRES 150April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Credit Union Administration relating to "Withdrawal of Fee Reporting Requirements".
Bill SJRES 142April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2023-02: Reopening Deposit Accounts That Consumers Previously Closed".
Bill SJRES 143April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Statement of Policy Regarding Prohibition on Abusive Acts or Practices".
Bill SJRES 147April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill SJRES 145April 1, 2026
ESCRA Act
Bill S 4144April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Fair Credit Reporting Act; Preemption of State Laws".
Bill SJRES 144April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Application of Regulation Z's Ability-To-Repay Rule to Certain Situations Involving Successors-In-Interest".
Bill SJRES 146April 1, 2026
Proprietary Education Oversight Task Force Act
Bill S 4056April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
Bill SJRES 141April 1, 2026